The oncogenic lncRNA LINC00662 activates Wnt/β-catenin signaling by upregulating WNT3A expression via competitive binding with miR-15a, miR-16, and miR-107, which directly target and inhibit the expression and translation of WNT3A in HCC. The gene discussed is WNT3A; the disease is hepatocellular carcinoma.